Key Statistics
Market Cap$40.81M
P/E Ratio1.9
Div. Yield—
EPS (TTM)$2.57
52W High$19.14
52W Low$3.92
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees14
Price Performance
1 Week+8.71%
3 Month-70.40%
1 Year-15.71%
FinancialsAnnual · QuiverQuant
Revenue$8.57M
Assets$165.50M
Liabilities$264.74M
Net Income$276.13M loss
About
Atara Biotherapeutics, Inc., a commercially available T-cell immunotherapy company, develops treatments for cancer patients, autoimmune and viral diseases in the United States. The company is headquartered in South San Francisco, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze ATRA with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.